BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1450204)

  • 1. Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens.
    Alving CR
    Biochim Biophys Acta; 1992 Dec; 1113(3-4):307-22. PubMed ID: 1450204
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity.
    van Houte AJ; Snippe H; Schmitz MG; Willers JM
    Immunology; 1981 Nov; 44(3):561-8. PubMed ID: 7033115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.
    Bakouche O; Gerlier D
    Immunology; 1986 Jul; 58(3):507-13. PubMed ID: 3733150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to phospholipids and liposomes: binding of antibodies to cells.
    Fogler WE; Swartz GM; Alving CR
    Biochim Biophys Acta; 1987 Oct; 903(2):265-72. PubMed ID: 2820489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.
    Moghimi SM; Hunter AC
    Pharm Res; 2001 Jan; 18(1):1-8. PubMed ID: 11336343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.
    Davis D; Gregoriadis G
    Immunology; 1987 Jun; 61(2):229-34. PubMed ID: 3596639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging.
    Alving CR
    Prog Clin Biol Res; 1990; 343():41-51. PubMed ID: 2198584
    [No Abstract]   [Full Text] [Related]  

  • 8. Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein.
    Rao M; Rothwell SW; Wassef NM; Koolwal AB; Alving CR
    Exp Cell Res; 1999 Jan; 246(1):203-11. PubMed ID: 9882529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition.
    Yasuda T; Dancey GF; Kinsky SC
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1234-6. PubMed ID: 265565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors.
    Dal Monte P; Szoka FC
    J Immunol; 1989 Mar; 142(5):1437-43. PubMed ID: 2465339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.
    Stier EM; Mandal M; Lee KD
    Mol Pharm; 2005; 2(1):74-82. PubMed ID: 15804180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
    Alving CR; Beck Z; Karasavva N; Matyas GR; Rao M
    Mol Membr Biol; 2006; 23(6):453-65. PubMed ID: 17127618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-coated liposomes. The role of non-specific antibody adsorption.
    Senior J; Waters JA; Gregoriadis G
    FEBS Lett; 1986 Feb; 196(1):54-8. PubMed ID: 3510909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural antibodies against phospholipids and liposomes in humans.
    Alving CR
    Biochem Soc Trans; 1984 Apr; 12(2):342-4. PubMed ID: 6724120
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen presentation by liposomes: inhibition with antibodies.
    Walden P; Nagy ZA; Klein J
    Eur J Immunol; 1986 Jun; 16(6):717-20. PubMed ID: 3013642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of antigen-presenting capacity to Ia-negative cells upon fusion with Ia-bearing liposomes.
    Coeshott C; Grey HM
    J Immunol; 1985 Mar; 134(3):1343-8. PubMed ID: 2981915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits.
    Richards RL; Aronson J; Schoenbechler M; Diggs CL; Alving CR
    J Immunol; 1983 Mar; 130(3):1390-4. PubMed ID: 6185580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of surface-linked liposomal antigens for the development of vaccines].
    Uchida T; Taneichi M
    Nihon Rinsho; 2008 Oct; 66(10):1894-902. PubMed ID: 18939487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by liposomes as model system for T-B cell interaction.
    Walden P
    Eur J Immunol; 1988 Nov; 18(11):1851-4. PubMed ID: 3264532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens.
    Bate CA; Taverne J; Bootsma HJ; Mason RC; Skalko N; Gregoriadis G; Playfair JH
    Immunology; 1992 May; 76(1):35-41. PubMed ID: 1628898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.